Mirtazapin Stada (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, increasing the release of norepinephrine, and antagonising postsynaptic 5‑HT2, 5‑HT3 and histamine H1 receptors. This combined action enhances serotonergic and noradrenergic neurotransmission while providing sedative and anti‑nausea effects that contribute to its antidepressant activity.

The appropriate dose of Mirtazapin Stada is determined by the prescribing clinician based on the individual’s clinical condition, response to therapy, age, liver and kidney function, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order Mirtazapin Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Mirtazapin Stada belongs to the NaSSA class, which differs from SSRIs that primarily inhibit serotonin reuptake. Mirtazapine’s receptor profile often results in stronger sedative and appetite‑stimulating effects, making it useful for patients with insomnia or weight loss, whereas SSRIs are generally more activating and have a different side‑effect spectrum.

Mirtazapin Stada should be stored at ambient temperature, below 25 °C, in its original packaging. It must be kept away from excess moisture, direct sunlight, and heat sources to maintain product stability and potency.

Mirtazapin Stada is taken orally, usually as a tablet. It can be swallowed with or without food, although taking it with a light snack may reduce occasional stomach upset. Patients should follow the dosing schedule prescribed by their clinician.

Serious risks include the emergence or worsening of suicidal thoughts, especially early in treatment, agranulocytosis or severe neutropenia, and rare but severe allergic reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if any of these events occur.

Mirtazapin Stada should be avoided in patients with known hypersensitivity to mirtazapine or any of its excipients, those currently taking monoamine oxidase inhibitors, or individuals with a history of severe agranulocytosis. Caution is also advised for patients with uncontrolled cardiovascular disease or severe hepatic impairment.